Audien Hearing Atom vs Otofonix Groove

The Audien Hearing Atom is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.3/5 in our lab testing. At $89, it represents one of the most affordable entry points into amplification, though its performance reflects that positioning with a rank of #52 among 65 OTC hearing aids tested. The Atom's standout strength is its excellent feedback handling, scoring a perfect 5.0/5—above the category average by 0.46 points. This means users can expect stable amplification without the whistling that can plague some budget devices. However, speech performance is more limited: speech in quiet scores a mixed 2.6/5 (0.15 points below category average), while speech in noise drops to a low 1.0/5 (0.48 points below average). A significant limitation is the complete lack of music streaming capability, scoring 0.0/5—nearly 2 points below the already-modest category average. Own-voice comfort also falls below average at 2.1/5. These results suggest the Atom is designed purely for basic amplification rather than multimedia use. The Atom may suit buyers seeking the most affordable path to mild amplification who prioritize stability over advanced features. However, several competitors in the same price range offer substantially better performance—some scoring a full point higher. Those willing to consider alternatives may find meaningfully better speech clarity and additional capabilities without significant price increases.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.